All physicians are faced with the challenge of how to help patients with no approved therapies for their diseases. What are ...

IQVIA Holdings Inc. (NYSE:IQV), a global leader in advanced analytics, technology solutions, and clinical research services for the healthcare and life sciences industries, finds itself at a critical ...

Statins help people manage high cholesterol levels, but many experts want to know if these drugs can also support brain ...

New heart health biopharmaceutical company Kardigan, which counts among its co-founders the director for Northwestern ...

Aardvark Therapeutics plans a $100M IPO for metabolic treatments, targeting rare Prader-Willi syndrome with a potential ...

APAC offers stability in an increasing challenging global geopolitical environment for clinical stage drug development.

In this video, Xiuning Le, MD, PhD, discusses the state of the pipeline for developing EGFR-mutated lung cancer treatments.

IRA has unintended consequences on investment landscape for small- and large-molecule drugs stifling the development of new ...

Day One Biopharma's OJEMDA FDA approval for pediatric glioma, but market concerns remain. Check out why I rate DAWN stock as ...

Wong, Founder and CEO of HCW Biologics, commented, “The FDA’s clearance to initiate our first-in-human clinical trial for HCW9302 brings us one step closer to advancing a potentially transformative ...

There is growing enthusiasm about China’s potential to speed up drug development with AI. And companies outside the country ...